SIRT1 and Parkinson disease: The use of SIRT1 inhibitors may lead to a loss of the protective capacity of curcumin, suggesting that curcumin may ameliorate the intestinal tract in PD through the SIRT1/NRF2 pathway via inflammation and pyroptosis.